Across TCGA pan-cancer cohorts, RPS3AP38 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated RPS3AP38 data layer.
The strongest signal is observed in mesothelioma (MESO), where higher RPS3AP38 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPS3AP38 expression acts as an unfavorable survival marker, although some lineages such as THYM and ESCA show a favorable association.
MESO, KIRC, and UVM are the cancer types where RPS3AP38 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.